Law360, Washington (February 23, 2012, 7:36 PM ET) -- Rep. Brian Bilbray, R-Calif., introduced a bill last week that would keep states from requiring drug and medical device makers to undergo inspections that duplicate those already deemed necessary by the U.S. Food and Drug Administration.
The bill, H.R 4056, introduced Feb. 16, would clarify areas in the Federal Food, Drug and Cosmetic Act to delineate what inspections are governed by the FDA rather than state public health departments, including facility inspections and product recalls.
Although California is the only state that requires life sciences companies...
House Bill Aims To Rein In State Drug, Device Inspections
To view the full article, take a free trial now.
